title: Tissue plasminogen activator: why the backlash?
authors.affiliation: Department of Medicine, University of Michigan Medical Center, Ann Arbor 48109-0022.
authors.forename: E J
authors.initials: EJ
authors.lastname: Topol
authors.forename: R M
authors.initials: RM
authors.lastname: Califf
mesh_terms: D002986:Clinical Trials as Topic; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D010919:Placebos; D011897:Random Allocation; D011994:Recombinant Proteins / Q000627:therapeutic use; D013300:Streptokinase / Q000627:therapeutic use; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
chemical_list: D010919:Placebos; D011994:Recombinant Proteins; D013300:Streptokinase; D010959:Tissue Plasminogen Activator